Introduction: A Nuclear Vision for Viksit Bharat@2047 As India marches toward its ambitious goal of becoming a developed nation by 2047, energy security stands as a pivotal pillar in the vision of Viksit Bharat . Amid the global climate crisis and rising energy demands, nuclear power has re-emerged as a compelling solution. India’s commitment to achieving 100 GW of nuclear power capacity by 2047 is both visionary and necessary—but achieving this requires a strategic shift in policy, participation, and international cooperation. While India’s nuclear energy sector has traditionally been a tightly controlled domain under government monopoly—primarily led by the Department of Atomic Energy (DAE) and Nuclear Power Corporation of India Limited (NPCIL) —it is now imperative to welcome private sector investments and foreign partnerships. A reformed nuclear ecosystem can unlock the full potential of atomic energy as a clean, reliable, and scalable contributor to India’s net-zero aspiration...
CAR T-Cell Therapy: A Revolutionary Cancer Treatment Introduction CAR T-cell therapy is an advanced form of immunotherapy that utilizes a patient's own immune cells (T-cells) to fight cancer. It has shown remarkable success in treating blood cancers like leukemia and lymphoma. Recently, the Central Drugs Standard Control Organisation (CDSCO) approved India's second "living drug," Qartemi, a CAR T-cell therapy for blood cancer treatment. What is CAR T-Cell Therapy? CAR (Chimeric Antigen Receptor) T-cell therapy is a type of personalized medicine that modifies a patient's T-cells in the laboratory to help them recognize and attack cancer cells. This therapy harnesses the power of the immune system to specifically target cancer cells while sparing healthy ones. How Does CAR T-Cell Therapy Work? The process involves several key steps: T-Cell Collection : A patient's T-cells (a type of white blood cell) are extracted from their blood using a process called leukaph...